Home › Funds › Silvant Capital Management LLC › COR
Silvant Capital Management LLC position in COR
CENCORA INC · Health Care
Silvant Capital Management LLC reported holding 33,603 shares of COR (CENCORA INC) in its Q3 2026 13F filing — a position valued at US$10.1M, representing 0.20% of its reported portfolio and ranking #46 among its reported holdings. Silvant Capital Management LLC has disclosed COR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Silvant Capital Management LLC's COR position evolved
Silvant Capital Management LLC first disclosed a stake in COR in Q3 2023 at 50,854 shares (US$9.2M). The position peaked in Q1 2024 at 50,854 shares, worth US$12.4M. Across 13 filings, Silvant Capital Management LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 33,603 shares valued at US$10.1M — a reduction of -8,541 shares quarter over quarter.. Notable position changes include a 29% trim in Q3 2024 (shares were roughly flat over the following quarter), a 31% increase in Q2 2026 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 50.85K | $9.15M | New |
| Q4 2023 | 50.85K | $10.44M | Hold |
| Q1 2024 | 50.85K | $12.36M | Hold |
| Q2 2024 | 50.85K | $11.46M | Hold |
| Q3 2024 | 36.01K | $8.11M | Reduce |
| Q4 2024 | 36.01K | $8.09M | Hold |
| Q1 2025 | 36.01K | $10.01M | Hold |
| Q2 2025 | 36.01K | $10.80M | Hold |
| Q3 2025 | 32.90K | $10.28M | Reduce |
| Q4 2025 | 33.44K | $11.29M | Add |
| Q1 2026 | 32.19K | $10.11M | Reduce |
| Q2 2026 | 42.14K | $11.93M | Add |
| Q3 2026 | 33.60K | $10.09M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COR and 13F data
COR (CENCORA INC) is a Health Care company. 33 other funds we track also report a position in COR — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$2.10B), Boston Partners (US$1.58B), Mawer Investment Management Ltd. (US$413.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COR
- T. Rowe Price Investment Management, Inc. 7.41M sh · $2.10B · Q2 2026
- Boston Partners 5.25M sh · $1.58B · Q3 2026
- Mawer Investment Management Ltd. 1.38M sh · $413.03M · Q3 2026
- Carmignac Gestion 1.34M sh · $403.82M · Q3 2026
- BESSEMER GROUP INC 1.26M sh · $376.94M · Q3 2026
More on Silvant Capital Management LLC
FAQ
How long has Silvant Capital Management LLC held COR?
Silvant Capital Management LLC has disclosed COR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Silvant Capital Management LLC's current position in COR?
As of Q3 2026, Silvant Capital Management LLC holds 33.60K shares of COR (CENCORA INC), valued at $10.09M, representing 0.20% of its reported portfolio and ranking #46.
Has Silvant Capital Management LLC been buying or selling COR?
In the latest 13F filing (Q3 2026), Silvant Capital Management LLC reduced its position in COR. The position peaked in Q1 2024 at 50.85K shares.
Which other funds hold COR?
Other major institutional holders of COR include T. Rowe Price Investment Management, Inc., Boston Partners, Mawer Investment Management Ltd., among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.